Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin vs Methotrexate in Systemic Sclerosis
NCT00241189Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2002
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in systemic sclerosis (SSc), sponsored by University of California, Los Angeles. Started Aug 2002; status: completed.
02
Drugs
sirolimus
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00241189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241189.